Bayesian Capital Management, LP Staar Surgical CO Transaction History

Bayesian Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$50.24 - $80.48 $262,001 - $419,703	5,215 Added 203.0%	7,784 $552,000
Q1 2022 May 16, 2022	BUY	$57.98 - $93.5 $148,950 - $240,201	2,569 New	2,569 $205,000
Q3 2020 Nov 12, 2020	SELL	$45.65 - $61.81 $191,730 - $259,602	-4,200 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$29.15 - $61.54 $138,724 - $292,868	-4,759 Reduced 53.12%	4,200 $258,000
Q1 2020 May 15, 2020	SELL	$25.01 - $42.4 $15,006 - $25,440	-600 Reduced 6.28%	8,959 $289,000
Q4 2019 Feb 14, 2020	BUY	$24.55 - $38.13 $234,673 - $364,484	9,559 New	9,559 $336,000
Q1 2019 May 14, 2019	SELL	$27.81 - $40.78 $831,880 - $1.22 Million	-29,913 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$28.91 - $50.0 $375,830 - $650,000	13,000 Added 76.86%	29,913 $955,000
Q3 2018 Nov 14, 2018	BUY	$30.85 - $50.65 $521,766 - $856,643	16,913 New	16,913 $812,000

249

47.4M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.15B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.